Nabriva Therapeutics plc (NBRV) plunged more than 27% and Heron Therapeutics Inc. (HRTX) slipped 18% on Thursday as both the companies were declined FDA approval for their respective investigational drugs.
from RTT - Biotech http://bit.ly/2ZYheCe
via IFTTT
No comments:
Post a Comment